Comprehensive Blood Panel for 48-Year-Old Male with History of Myalgia
For a 48-year-old male with past myalgia, order: complete blood count, comprehensive metabolic panel (including creatinine, glucose, liver function tests, calcium, alkaline phosphatase), creatine kinase (CK), erythrocyte sedimentation rate (ESR) or C-reactive protein (CRP), thyroid stimulating hormone (TSH), and vitamin D as your initial comprehensive panel.
Algorithmic Approach to Laboratory Testing
Core Essential Tests
The foundation of your workup should include:
- Complete blood count - screens for systemic disease and infection
- Comprehensive metabolic panel - establishes baseline renal/hepatic function and identifies metabolic derangements
- Creatine kinase (CK) - the primary muscle enzyme marker for muscle damage 1, 2
- ESR or CRP - identifies inflammatory processes
- TSH - excludes thyroid-related myopathy
- Vitamin D - common deficiency associated with myalgia
This panel is derived from the EULAR/ACR polymyalgia rheumatica guidelines 3, which provide the most comprehensive framework for evaluating muscle complaints, even though your patient may not have PMR specifically. The guideline's laboratory dataset serves as an excellent template for any patient presenting with myalgia.
Additional Tests to Consider Based on Clinical Context
Add these if warning symptoms are present 1:
- Rheumatoid factor and/or anti-CCP antibodies - if joint involvement or systemic symptoms
- Protein electrophoresis - if age >60 or constitutional symptoms suggesting malignancy
- Aldolase and AST - can be used in conjunction with CK for better diagnostic accuracy 2
Key Clinical Decision Points
When CK is persistently elevated (>1000 U/L), even without symptoms, this warrants further investigation including possible EMG, MRI, or muscle biopsy 1.
If myalgia is exercise-related, suspect metabolic myopathy and consider forearm ischemic exercise testing and potentially muscle biopsy 4, 5.
Do NOT routinely order extensive autoimmune panels (ANA, ANCA, myositis-specific antibodies) unless there are specific warning symptoms such as:
- Weakness in distinct muscle groups
- Skin changes suggesting dermatomyositis
- Dysphagia or bulbar signs
- Signs of systemic autoimmune disease 6, 1
Common Pitfalls to Avoid
- Don't over-test initially - the temptation with nonspecific myalgia is to order extensive autoimmune panels that are low-yield and lead to false positives 4
- CK can be falsely elevated after exercise, intramuscular injections, or in individuals with high muscle mass - repeat if elevated
- Isolated myalgia without weakness rarely represents inflammatory myositis 6
- Normal CK does not exclude all muscle disease - some metabolic and mitochondrial myopathies can present with normal CK 5
Interpretation Framework
The laboratory evaluation should be tailored rather than routine 6. Since your patient has a history of myalgia but is currently not on medications and presumably not acutely symptomatic, the comprehensive panel above establishes a baseline and screens for common treatable causes (thyroid disease, vitamin D deficiency, metabolic abnormalities) while avoiding unnecessary testing.
If this initial panel is unrevealing and symptoms persist or worsen, then escalate to specialized testing including myositis antibodies, imaging, or EMG based on evolving clinical features 6, 1.